|
1
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Timmermans M, Sonke GS, Slangen BFM,
Baalbergen A, Bekkers RLM, Fons G, Gerestein CG, Kruse AJ, Roes EM,
Zusterzeel PLM, et al: Outcome of surgery in advanced ovarian
cancer varies between geographical regions; opportunities for
improvement in the netherlands. Eur J Surg Oncol. 45:1425–1431.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morice P, Gouy S and Leary A: Mucinous
ovarian carcinoma. N Engl J Med. 380:1256–1266. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stewart C, Ralyea C and Lockwood S:
Ovarian cancer: An integrated review. Semin Oncol Nurs. 35:151–156.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zang J, Lu D and Xu A: The interaction of
circRNAs and RNA binding proteins: An important part of circRNA
maintenance and function. J Neurosci Res. Dec 21–2018.(Epub ahead
of print). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hao L, Rong W, Bai L, Cui H, Zhang S, Li
Y, Chen D and Meng X: Upregulated circular RNA circ_0007534
indicates an unfavorable prognosis in pancreatic ductal
adenocarcinoma and regulates cell proliferation, apoptosis, and
invasion by sponging miR-625 and miR-892b. J Cell Biochem.
120:3780–3789. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu Y, Yao Y, Zhong X, Leng K, Qin W, Qu L,
Cui Y and Jiang X: Downregulated circular RNA hsa_circ_0001649
regulates proliferation, migration and invasion in
cholangiocarcinoma cells. Biochem Biophys Res Commun. 496:455–461.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aufiero S, Reckman YJ, Pinto YM and
Creemers EE: Circular RNAs open a new chapter in cardiovascular
biology. Nat Rev Cardiol. 16:503–514. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li KS, Pan F, Mao XD, Liu C and Chen YJ:
Biological functions of circular RNAs and their roles in occurrence
of reproduction and gynecological diseases. Am J Transl Res.
11:1–15. 2019.PubMed/NCBI
|
|
13
|
Bach DH, Lee SK and Sood AK: Circular RNAs
in cancer. Mol Ther Nucleic Acids. 16:118–129. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang W, Liu Y, Gao R, Xiu Z and Sun T:
Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721
cell proliferation, vasculogenic mimicry, and radioresistance. Cell
Signal. 60:122–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matboli M, Shafei AE, Ali MA, Ashry AM,
Kamal KM, Agag MA, Reda I, Tash EF and Ali M: circRNAs
(hsa_circ_00156, hsa_circ_000224, and hsa_circ_000520) are novel
potential biomarkers in hepatocellular carcinoma. J Cell Biochem.
Nov 13–2018.(Epub ahead of print).
|
|
16
|
Guo J, Duan H, Li Y, Yang L and Yuan L: A
novel circular RNA circ-ZNF652 promotes hepatocellular carcinoma
metastasis through inducing snail-mediated epithelial-mesenchymal
transition by sponging miR-203/miR-502-5p. Biochem Biophys Res
Commun. 513:812–819. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang T and Wang X, Du Q, Wu N, Liu X, Chen
Y and Wang X: The circRNA circP4HB promotes NSCLC aggressiveness
and metastasis by sponging miR-133a-5p. Biochem Biophys Res Commun.
513:904–911. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao Y, Zhang C, Liu Y and Wang M: Circular
RNA profiling reveals circRNA1656 as a novel biomarker in high
grade serous ovarian cancer. Biosci Trends. 13:204–211. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan H, Tang L, Jiang H, Li X, Wang R, Gao
J and Li Q: Enhanced expression of circ_0000267 in hepatocellular
carcinoma indicates poor prognosis and facilitates cell progression
by sponging miR-646. J Cell Biochem. Feb 5–2019.(Epub ahead of
print). View Article : Google Scholar :
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang C, Wei Y, Yu L and Xiao Y:
Identification of altered circular RNA expression in serum exosomes
from patients with papillary thyroid carcinoma by high-throughput
sequencing. Med Sci Monit. 25:2785–2791. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Teng F, Xu J, Zhang M, Liu S, Gu Y, Zhang
M, Wang X, Ni J, Qian B, Shen R and Jia X: Comprehensive circular
RNA expression profiles and the tumor-suppressive function of
circHIPK3 in ovarian cancer. Int J Biochem Cell Biol. 112:8–17.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mao W, Huang X, Wang L, Zhang Z, Liu M, Li
Y, Luo M, Yao X, Fan J and Geng J: Circular RNA hsa_circ_0068871
regulates FGFR3 expression and activates STAT3 by targeting
miR-181a-5p to promote bladder cancer progression. J Exp Clin
Cancer Res. 38:1692019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, He M, Guo J and Cao T: Upregulation
of circular RNA circ-ERBB2 predicts unfavorable prognosis and
facilitates the progression of gastric cancer via miR-503/CACUL1
and miR-637/MMP-19 signaling. Biochem Biophys Res Commun.
511:926–930. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lei B, Huang Y, Zhou Z, Zhao Y, Thapa AJ,
Li W, Cai W and Deng Y: Circular RNA hsa_circ_0076248 promotes
oncogenesis of glioma by sponging miR-181a to modulate SIRT1
expression. J Cell Biochem. 120:6698–6708. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou YX, Wang C, Mao LW, Wang YL, Xia LQ,
Zhao W, Shen J and Chen J: Long noncoding RNA HOTAIR mediates the
estrogen-induced metastasis of endometrial cancer cells via the
miR-646/NPM1 axis. Am J Physiol Cell Physiol. 314:C690–C701. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang P, Tang WM, Zhang H, Li YQ, Peng Y,
Wang J, Liu GN, Huang XT, Zhao JJ, Li G, et al: MiR-646 inhibited
cell proliferation and EMT-induced metastasis by targeting FOXK1 in
gastric cancer. Br J Cancer. 117:525–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang YS, Chen T, Cai YJ, Dong J, Bai F,
Gao X, Tian L, Duan N and Liu D: MicroRNA-647 promotes the
therapeutic effectiveness of argon-helium cryoablation and inhibits
cell proliferation through targeting TRAF2 via the NF-κB signaling
pathway in non-small cell lung cancer. Onco Targets Ther.
11:6777–6784. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye G, Huang K, Yu J, Zhao L, Zhu X, Yang
Q, Li W, Jiang Y, Zhuang B, Liu H, et al: MicroRNA-647 targets
SRF-MYH9 axis to suppress invasion and metastasis of gastric
cancer. Theranostics. 7:3338–3353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ralston E, Beushausen S and Ploug T:
Expression of the synaptic vesicle proteins VAMPs/synaptobrevins 1
and 2 in non-neural tissues. J Biol Chem. 269:15403–15406.
1994.PubMed/NCBI
|
|
33
|
Raja SA, Abbas S, Shah STA, Tariq A, Bibi
N, Yousuf A, Khawaja A, Nawaz M, Mehmood A, Khan MJ and Hussain A:
Increased expression levels of Syntaxin 1A and Synaptobrevin
2/vesicle-associated membrane protein-2 are associated with the
progression of bladder cancer. Genet Mol Biol. 42:40–47. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li L, Wang X and Liu D: MicroRNA-185
inhibits proliferation, migration and invasion in human
osteosarcoma MG63 cells by targeting vesicle-associated membrane
protein 2. Gene. 696:80–87. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wade M, Li YC and Wahl GM: MDM2, MDMX and
p53 in oncogenesis and cancer therapy. Nat Rev Cancer. 13:83–96.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vassilev LT, Vu BT, Graves B, Carvajal D,
Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, et
al: In vivo activation of the p53 pathway by small-molecule
antagonists of MDM2. Science. 303:844–848. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sawada R, Maehara R, Oshikiri T, Nakamura
T, Itoh T, Kodama Y, Kakeji Y and Zen Y: MDM2 copy number increase:
A poor prognostic, molecular event in esophageal squamous cell
carcinoma. Hum Pathol. 89:1–9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang W, Wu J, Fei X, Chen W, Li Y, Shen K
and Zhu L: CHD1L promotes cell cycle progression and cell motility
by up-regulating MDM2 in breast cancer. Am J Transl Res.
11:1581–1592. 2019.PubMed/NCBI
|
|
39
|
Tang Y, Xuan Y, Qiao G, Ou Z, He Z, Zhu Q,
Liao M and Yin G: MDM2 promotes epithelial-mesenchymal transition
through activation of Smad2/3 signaling pathway in lung
adenocarcinoma. Onco Targets Ther. 12:2247–2258. 2019. View Article : Google Scholar : PubMed/NCBI
|
